News for LakeShore Biopharma Company Limited Registered Shs

TipRanks 40d

LakeShore Biopharma’s Financial Leap and Rabies Vaccine Trial Approval

GlobeNewswire 47d

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

TipRanks 47d

LakeShore Biopharma provides update on ongoing investigation involving Yi Zhang

TipRanks 47d

LakeShore Biopharma Faces Challenges Amid Criminal Probe into Former Chairman

GlobeNewswire 82d

LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan

TipRanks 82d

LakeShore Biopharma Advances PIKA Rabies Vaccine Approval

TipRanks 82d

LakeShore Biopharma initiates BLA submission to DRAP for PIKA rabies vaccine

TipRanks 88d

LakeShore Biopharma Announces Leadership Transition

TipRanks 91d

LakeShore Biopharma Achieves Nasdaq Compliance Milestone

TipRanks 91d

LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement

TipRanks 95d

LakeShore Biopharma Advances with Rabies Vaccine Trial

TipRanks 95d

LakeShore’s YSJA rabies vaccine receives approval for Phase III trial in China

Seeking Alpha 112d

LakeShore Biopharma provides HY guidance